Anti-CD20 Reference Antibody (obinutuzumab)
- Product Code: 139865
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of chronic lymphocytic leukemia (CLL) and certain types of non-Hodgkin’s lymphoma. It works by targeting CD20, a protein found on the surface of B-cells, leading to their destruction through immune-mediated mechanisms such as antibody-dependent cellular cytotoxicity and direct induction of apoptosis. Often used in combination with chemotherapy or other targeted agents, it helps reduce tumor burden and prolong progression-free survival in patients. Also investigated in autoimmune conditions involving abnormal B-cell activity.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | $197.89 |
+
-
|
Anti-CD20 Reference Antibody (obinutuzumab)
Used in the treatment of chronic lymphocytic leukemia (CLL) and certain types of non-Hodgkin’s lymphoma. It works by targeting CD20, a protein found on the surface of B-cells, leading to their destruction through immune-mediated mechanisms such as antibody-dependent cellular cytotoxicity and direct induction of apoptosis. Often used in combination with chemotherapy or other targeted agents, it helps reduce tumor burden and prolong progression-free survival in patients. Also investigated in autoimmune conditions involving abnormal B-cell activity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :